Raia Drogasil (OTCMKTS:RADLY) Stock Price Breaks Below 200 Day Moving Average – Here’s What Happened

Raia Drogasil S.A. (OTCMKTS:RADLY) crossed below its 200-day moving average during trading on Monday. The stock has a 200-day moving average of $4.12 and traded as low as $2.80. Raia Drogasil shares last traded at $2.85, with a volume of 187,774 shares.

Analyst Upgrades and Downgrades

Separately, Jefferies Financial Group raised Raia Drogasil to a “buy” rating and set a $5.20 target price on the stock in a report on Sunday, October 18th. One equities research analyst has rated the stock with a Buy rating and one has given a Hold rating to the stock. According to data from MarketBeat, Raia Drogasil presently has a consensus rating of “Moderate Buy” and an average target price of $5.20.

Raia Drogasil Stock Performance

The company has a debt-to-equity ratio of 0.99, a current ratio of 1.41 and a quick ratio of 0.58. The stock has a market cap of $3.80 billion and a P/E ratio of 19.27. The stock has a 50-day simple moving average of $3.78 and a 200-day simple moving average of $4.10.

Raia Drogasil (OTCMKTS:RADLY) last posted its earnings results on Tuesday, August 4th. The company reported $0.05 EPS for the quarter, hitting analysts’ consensus estimates of $0.05. The firm had revenue of $2.17 billion during the quarter, compared to analysts’ expectations of $2.32 billion. Raia Drogasil had a net margin of 2.99% and a return on equity of 20.12%. Research analysts forecast that Raia Drogasil S.A. will post 0.17 earnings per share for the current year.

Raia Drogasil Company Profile

Raia Drogasil, now operating under the name RD Saúde, is a Brazilian healthcare and pharmacy retail company. It operates a network of pharmacies offering prescription medicines, over-the-counter drugs, vitamins, personal care products, beauty items and other health-related merchandise.

The company also provides digital purchasing and delivery services through its online channels, supporting customers with prescription fulfillment, health products and related services. Its operations include pharmacy-based healthcare initiatives designed to complement its retail business and improve access to everyday healthcare.

RD Saúde was created in 2011 through the merger of Drogasil and Droga Raia, two established Brazilian pharmacy chains.